HC Wainwright Reiterates Buy Rating for FibroBiologics (NASDAQ:FBLG)
FibroBiologics (NASDAQ:FBLG – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $12.00 price target on the stock. HC Wainwright also issued estimates for FibroBiologics’ Q1 2025 earnings at ($0.11) EPS, Q2 2025 earnings at ($0.11) EPS, […]
FibroBiologics (NASDAQ:FBLG – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $12.00 price target on the stock. HC Wainwright also issued estimates for FibroBiologics’ Q1 2025 earnings at ($0.11) EPS, Q2 2025 earnings at ($0.11) EPS, […]
